EQO is a biotechnology company, yet not operating in the field of human health. Rather, we are dedicated to leveraging biotech to address challenges in aquatic ecosystems, which refers to lakes, rivers, wetlands, estuaries, and other surface water assets.

 

EQO offers 2 next-gen field tools, the Osprey & the Calypso, which leverage our proprietary IP to capture the eRNA of animal or microbial populations in question. Our lab support includes eRNA and eDNA sample processing and metagenomic/bioinformatic tools to support our clients: 1) prevent invasive species infestations; 2) track native and endangered species; and 3) identify toxic organisms.

 

EQO’s public and private sector clients own or manage lakes, rivers, reservoirs, wetlands, or other watershed ‘assets’ that are facing increasing stress due to the effects of a warmer atmosphere or pollution/run-off. Just like a human dealing with illness, the path to aquatic ecosystem health, safety, and biodiversity begins with diagnostics.   

​